zofenopril has been researched along with Metabolic Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borghi, C; Napoli, C; Omboni, S | 1 |
| Ambrosioni, E; Borghi, C; Cicero, AF | 1 |
2 trial(s) available for zofenopril and Metabolic Syndrome
| Article | Year |
|---|---|
Fixed-dose combination of zofenopril plus hydrochlorothiazide vs. irbesartan plus hydrochlorothiazide in hypertensive patients with established metabolic syndrome uncontrolled by previous monotherapy. The ZAMES study (Zofenopril in Advanced MEtabolic Synd
Topics: Aged; Biphenyl Compounds; Captopril; Female; Humans; Hydrochlorothiazide; Irbesartan; Male; Metabolic Syndrome; Middle Aged; Tetrazoles | 2016 |
Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Comorbidity; Female; Heart Failure; Humans; Incidence; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction | 2008 |